Single- vs. Multiple-Item Instruments in the Assessment of Quality of Life in Patients with Advanced Cancer
Accepted 29 August 2009.
Abstract
Although multidimensional instruments are usually used to measure quality of life in advanced cancer patients, recent research suggests that single-item assessments can provide a reliable measure. Using the Functional Assessment of Cancer Therapy-General (FACT-G) instrument as a gold standard, we assessed the performance of the Edmonton Symptom Assessment System “feeling of well-being” (ESAS WB) item. We reviewed the data from 213 patients enrolled in six clinical trials. We determined the association between baseline ESAS WB and FACT-G total and subscale domain scores (Physical Well-being [PWB], Social/Family Well-being [SWB], Emotional Well-being [EWB], and Functional Well-being [FWB]. We also calculated the association between baseline (T1) and second (T2) observations of ESAS WB and of FACT-G total score. In addition, we predicted the change in FACT-G predicted by the ESAS WB score using regression analysis. Mean age was 60 (SD 12) years and 48% were female. The Spearman correlation coefficient of ESAS WB and FACT-G was −0.48 (P<0.0001). Correlations with FACT-G subscale domains were also highly significant, except for the SWB domain (P=0.08). The Pearson correlation coefficient for T1–T2 in ESAS WB and FACT-G for 146 patients was −0.36 (P<0.0001). The change in ESAS WB corresponding to FACT-G published minimally important difference was −0.24 for 3, −1.55 for 5, and −2.87 for 7, respectively. These results suggest that the single-item measure ESAS WB best reflects the total score on the FACT-G and PWB, EWB, and FWB domains but not on the SWB domain.
aDepartment of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
bMcCulloch House, Southern Health Care Network, Melbourne, Victoria, Australia
cFaculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia
Address correspondence to: Eduardo Bruera, MD, Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Unit 1414, 1515 Holcombe Blvd., Houston, TX 77030, USA.
Eduardo Bruera is supported in part by National Institutes of Health grants: RO1NR010162-01A1, RO1CA122292-01, and RO1CA124481-01. The authors declare no conflicts of interest.
Some of the results of this paper are available as an online publish-only abstract (Permanent Abstract ID: e20528) from the Annual Meeting of the American Society of Clinical Oncology, Orlando, Florida, May 29–June 2, 2009. This paper also has been partially presented at the Multinational Association of Supportive Care in Cancer (MASCC) 2009 International Symposium on Supportive Care in Cancer, Rome, Italy, June 25–27, 2009.